A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients (Q34288828)

1 August 2017

A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients (English)

1 reference

1 August 2017

1 reference

1 reference

6

1 reference

1 August 2017

Cameron P Simmons

25

0 references

Martin L. Hibberd

Martin L Hibberd

12

0 references

Andreas Wilm

Andreas Wilm

14

0 references

Laura Merson

Laura Merson

10

0 references

Marcel Wolbers

23

Marcel Wolbers

1 reference

1 August 2017

4

Kien Thi Hue Duong

1 reference

1 August 2017

11

Long Truong Hoang

1 reference

1 August 2017

18

Truong Thanh Nguyen

1 reference

1 August 2017

22

Rosemary Petric

1 reference

1 August 2017

Nguyet Minh Nguyen

1

1 reference

1 August 2017

Chau Nguyen Bich Tran

2

1 reference

1 August 2017

Lam Khanh Phung

3

1 reference

1 August 2017

Huy le Anh Huynh

5

1 reference

1 August 2017

Quyen Than Ha Nguyen

7

1 reference

1 August 2017

Hien Tinh Tran

8

1 reference

1 August 2017

Chau Van Vinh Nguyen

9

1 reference

1 August 2017

Pauline P K Aw

13

1 reference

1 August 2017

Niranjan Nagarajan

15

1 reference

1 August 2017

Dung Thi Nguyen

16

1 reference

1 August 2017

Mai Phuong Pham

17

1 reference

1 August 2017

Hassan Javanbakht

19

1 reference

1 August 2017

Klaus Klumpp

20

1 reference

1 August 2017

Janet Hammond

21

1 reference

1 August 2017

Chinh Tran Nguyen

24

1 reference

1 August 2017

language of work or name

English

0 references

publication date

17 July 2012

1 reference

Journal of Infectious Diseases

1 August 2017

1 reference

1 August 2017

207

1 reference

1 August 2017

1442-1450

1 reference

1 August 2017

9

1 reference

Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

The pathogenesis of dengue

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

Strategies for development of Dengue virus inhibitors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

An adenosine nucleoside inhibitor of dengue virus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

Cost of dengue cases in eight countries in the Americas and Asia: a prospective study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610419

Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS470

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIS470

1 reference

1 August 2017

1 reference

1 August 2017

1 reference